Assays for Hepatitis B Virus DNA-and RNA-Dependent DNA Polymerase Activities

  • Timothy Shaw
  • Stephen A. Locarnini
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 24)


Genomes of the hepatitis B viruses (HBVs) consist of approx 3.2 kb of partly double-stranded DNA containing three or four overlapping open reading frames, the largest of which encodes the viral polymerase (Pol) protein. After entry into the cell and uncoating, the viral genome is transported to the nucleus where it is converted into a covalently closed circular (CCC) or supercoiled molecule by cellular repair mechanisms. The viral CCC DNA is transcribed, presumably by host cell RNA polymerase II, into unspliced, capped polyadenylated mRNA species from which viral proteins are transcribed. In addition, terminally redundant 3.5-kb RNA transcripts, which function as pregenomes, are produced and exported to the cytoplasm where they are packaged into viral core particles in which reverse transcription, pregenome degradation, and duplication occurs, reproducing the partly double-stranded HBV genome (for recent review, see ref. 1). Besides its essential role in HBV genome replication, HBV Pol is also involved in virus assembly, and because hepadnaviruses do not encode enzymes functionally equivalent to deoxynucleoside kinases (2), functions associated with HBV Pol are probably the only virus-specific targets for antiviral activity of nucleoside analogs. In vitro assays for inhibition of HBV Pol functions by deoxynucleoside triphosphate (dNTP) analogs are useful indicators but, because of restrictions imposed by hepatocyte enzymology, provide no guarantee of potential anti-HBV activity of the parent (deoxy)nucleoside analogs in intact cells (2).


Small Aliquot Microfuge Tube Core Preparation Cellular Repair Mechanism Phosphonoformic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Nassal, M. and Schaller, H. (1996) Hepatitis B virus replication—an update. J. Viral Hepatitis 3, 217–226.CrossRefGoogle Scholar
  2. 2.
    Shaw, T. and Locarnini, S. A. (1995) Hepatic purine and pyrimidine metabolism: implications for antiviral chemotherapy of viral hepatitis. Liver 15, 169–184.PubMedGoogle Scholar
  3. 3.
    Oberhaus, S. M. and Newbold, J. E. (1996) In situ DNA polymerase and RNase H activity gel assays as applied to hepadnavirus particles. Methods Enzymol. 275, 328–347.CrossRefPubMedGoogle Scholar
  4. 4.
    Howe, A.Y. M., Elliott J. F., and Tyrrell, D. L. J. (1992) Duck hepatitis B virus polymerase produced by in vitro transcription and translation possesses DNA polymerase and reverse transcriptase activities. Biochem. Biopyhs. Res. Commun. 189, 1170–1176.CrossRefGoogle Scholar
  5. 5.
    Jeong, J. H., Kwak, D. S., Rho, H. M., and Jung, G. (1996) The catalytic properties of human hepatitis B virus polymerase. Biochem. Biopyhs. Res. Commun. 223, 264–271.CrossRefGoogle Scholar
  6. 6.
    Lanford, R. E., Notvall, L., and Beames, B. (1995) Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J. Virol. 69, 4431–4439.PubMedGoogle Scholar
  7. 7.
    Sells, M. A., Chen, M. L., and Acs, G. (1987) Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 75, 4533–4537.Google Scholar
  8. 8.
    Moore, D. (1995) Preparation and analysis of DNA, in Current Protocols in Molecular Biology, vol. 1 (Absubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Siedman, J. G., Smith, J. A., and Struhl, K., eds.), Wiley, New York.Google Scholar
  9. 9.
    Shaw, T., Mok, S. S., and Locarnini, S. A. (1996) Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. Hepatology 24, 996–1002.CrossRefPubMedGoogle Scholar
  10. 10.
    Severini, A., Liu, X.-Y., Wilson, J. S., and Tyrrell, D. L. J. (1995) Mechanism of inhibition of duck hepatitis B virus polymerase by (−)-β-L-2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents. Chemother. 39, 1430–1435.PubMedGoogle Scholar
  11. 11.
    Engel, P. C. (ed.) (1996) Enzymology LABFAX. Bios Scientific Publishers, Oxford, UKGoogle Scholar
  12. 12.
    Kock, J. and Schlicht, H.-J. (1993) Analysis of the earliest steps of hepadnavirus replication: Genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J. Virol. 67, 4867–4874.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  • Timothy Shaw
    • 1
  • Stephen A. Locarnini
    • 2
  1. 1.Victorian Infectious Diseases Reference LaboratoryCarltonAustralia
  2. 2.Research and Molecular DevelopmentVictorian Infectious Diseases Reference LaboratoryNorth MelbourneAustralia

Personalised recommendations